Page last updated: 2024-08-24

plerixafor and Acquired Immunodeficiency Syndrome

plerixafor has been researched along with Acquired Immunodeficiency Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cilliers, T; Coetzer, M; Ketas, T; Moore, JP; Morris, L; Nhlapo, J; Olson, WC; Orlovic, D; Trkola, A	1
Schols, D	1

Other Studies

2 other study(ies) available for plerixafor and Acquired Immunodeficiency Syndrome

Article	Year
The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. Journal of virology, 2003, Volume: 77, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Amino Acid Sequence; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzylamines; CCR5 Receptor Antagonists; Cell Line; Chemokine CCL5; Cyclams; Female; Heterocyclic Compounds; HIV Antibodies; HIV Envelope Protein gp120; HIV-1; Humans; In Vitro Techniques; Male; Molecular Sequence Data; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Sequence Homology, Amino Acid; South Africa; Transfection; Virus Replication	2003
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1999, Volume: 61, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Benzylamines; Cyclams; Heterocyclic Compounds; HIV; HIV Infections; Humans; Receptors, CXCR4; T-Lymphocytes	1999

Article

Year

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

Journal of virology, 2003, Volume: 77, Issue:7

Topics: Acquired Immunodeficiency Syndrome; Adult; Amino Acid Sequence; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzylamines; CCR5 Receptor Antagonists; Cell Line; Chemokine CCL5; Cyclams; Female; Heterocyclic Compounds; HIV Antibodies; HIV Envelope Protein gp120; HIV-1; Humans; In Vitro Techniques; Male; Molecular Sequence Data; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Sequence Homology, Amino Acid; South Africa; Transfection; Virus Replication

2003

Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1999, Volume: 61, Issue:4

Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Benzylamines; Cyclams; Heterocyclic Compounds; HIV; HIV Infections; Humans; Receptors, CXCR4; T-Lymphocytes

1999